MIRA | tickerfilter.com

Fundamental analysis

27%

Profitability 0%

Dept financing 15%

Liquidity 50%

Performance 50%

Company vs Stock growth

N/A

1.060 1.060

0.000 0%

+ Add row to compare

Performance

5 Days

-10.80%

1 Month

-17.24%

3 Months

-22.06%

6 Months

-22.06%

1 Year

-22.06%

2 Year

-22.06%

Key data

Stock price

$0.80

P/E Ratio

0.00

DAY RANGE

$0.73 - $0.84

EPS

-$0.14

52 WEEK RANGE

$0.73 - $1.33

52 WEEK CHANGE

-$22.06

MARKET CAP

18.879 M

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-15-2025

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$174,677

AVERAGE 30 VOLUME

$359,887

Company detail

CEO: Erez Aminov
Region: US
Website: www.mirapharmaceuticals.com
Employees: 0
IPO year: 2023

Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are an early pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic THC analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. Our corporate headquarters is located at 855 N Wolfe Street, Suite 601, Baltimore, Maryland.

MIRA - MIRA PHARMACEUTICALS, INC.